The USC Marshall School of Business today announced the finalists of the Asia-Pacific BioBusiness Leadership Award 2005 to be presented at its annual Asia-Pacific Business Outlook Conference on April
March 14, 2005 (Press Release) --
March 15, 2005 – Los Angeles, CA, – The USC Marshall School of Business today announced the finalists of the Asia-Pacific BioBusiness Leadership Award 2005 to be presented at its annual Asia-Pacific Business Outlook Conference on April 7, 2005.
The Asia-Pacific BioBusiness Leadership Award recognizes leaders (individuals, organizations and corporations) that best exemplify the spirit of innovation, enterprise and entrepreneurship in areas of biobusiness (healthcare, biomedical, agricultural, food, environmental and emerging technology areas in the life sciences and biotechnology). Future awards include the North American, European, Latin America/Caribbean, Africa/Middle East and Global Awards (see www.marshall.usc.edu/biobusiness for details).
The 5 finalists for the Asia-Pacific BioBusiness Leadership Award are (in alphabetical order):
Dr. Joong-Myung Cho (Korea) – former R&D Director at LG Chemicals, holder of over 110 patents, and founder of Crystal Genomics, a biopharmaceutical start-up specializing in structure-based drug development. He is considered to be among the leading experts in drug design and development in the Asia-Pacific.
Dr. Krishna M. Ella (India) – the scientist-entrepreneur behind Bharat Biotech, an innovative biotech company in India that is poised to establish itself as a global player, and has developed and brought a range of vaccines and promising novel molecules to market.
Mr. Yoh-Chie Lu (China/Singapore/USA) – founder of Biosensors, and the person behind one of the most successful medical device licensing deals out of Asia when Biosensors out-licensed its bio-absorbable polymer cardiovascular stents to Guidant in 2003.
Dr. Swati Piramal (India) – the scientific and technical driver for the growth of Nicholas Piramal, a leading pharmaceutical player in India whose annual revenues increased from less than $4 million in the late 1980’s to over $250 million through a series of strategic acquisitions, and innovative new product introductions.
Dr. Prathap C. Reddy (India) – founder and architect of the Apollo Hospital Group, the largest hospital and healthcare services network in Asia with over 35 hospitals throughout South Asia and a patient base of over 7 million.
A Selection Committee of international experts in biobusiness is responsible for judging the nominations for the Asia-Pacific BioBusiness Leadership Award.
Leading the Selection Committee is Carl Feldbaum, President Emeritus of the U.S. Biotechnology Industry Organization (BIO). Other judges on the committee include:
James Foley, Ph.D., Vice President of Business Development, Japan/International, Bristol-Myers Squibb Co.
Mario Gobbo, Ph.D., Head of Life Sciences, International Finance Corporation, The World Bank Group
Hugh Purser, Coordinator, Global BioBusiness Entrepreneur Network (GBEN)
The Regional and Global BioBusiness Leadership Awards are sponsored by the Global BioBusiness Initiative, a program of the Center for Global Business Excellence (C-GLOBE), USC Marshall School of Business.
The Asia-Pacific BioBusiness Leadership Award recognizes leaders (individuals, organizations and corporations) that best exemplify the spirit of innovation, enterprise and entrepreneurship in areas of biobusiness (healthcare, biomedical, agricultural, food, environmental and emerging technology areas in the life sciences and biotechnology). Future awards include the North American, European, Latin America/Caribbean, Africa/Middle East and Global Awards (see www.marshall.usc.edu/biobusiness for details).
The 5 finalists for the Asia-Pacific BioBusiness Leadership Award are (in alphabetical order):
Dr. Joong-Myung Cho (Korea) – former R&D Director at LG Chemicals, holder of over 110 patents, and founder of Crystal Genomics, a biopharmaceutical start-up specializing in structure-based drug development. He is considered to be among the leading experts in drug design and development in the Asia-Pacific.
Dr. Krishna M. Ella (India) – the scientist-entrepreneur behind Bharat Biotech, an innovative biotech company in India that is poised to establish itself as a global player, and has developed and brought a range of vaccines and promising novel molecules to market.
Mr. Yoh-Chie Lu (China/Singapore/USA) – founder of Biosensors, and the person behind one of the most successful medical device licensing deals out of Asia when Biosensors out-licensed its bio-absorbable polymer cardiovascular stents to Guidant in 2003.
Dr. Swati Piramal (India) – the scientific and technical driver for the growth of Nicholas Piramal, a leading pharmaceutical player in India whose annual revenues increased from less than $4 million in the late 1980’s to over $250 million through a series of strategic acquisitions, and innovative new product introductions.
Dr. Prathap C. Reddy (India) – founder and architect of the Apollo Hospital Group, the largest hospital and healthcare services network in Asia with over 35 hospitals throughout South Asia and a patient base of over 7 million.
A Selection Committee of international experts in biobusiness is responsible for judging the nominations for the Asia-Pacific BioBusiness Leadership Award.
Leading the Selection Committee is Carl Feldbaum, President Emeritus of the U.S. Biotechnology Industry Organization (BIO). Other judges on the committee include:
James Foley, Ph.D., Vice President of Business Development, Japan/International, Bristol-Myers Squibb Co.
Mario Gobbo, Ph.D., Head of Life Sciences, International Finance Corporation, The World Bank Group
Hugh Purser, Coordinator, Global BioBusiness Entrepreneur Network (GBEN)
The Regional and Global BioBusiness Leadership Awards are sponsored by the Global BioBusiness Initiative, a program of the Center for Global Business Excellence (C-GLOBE), USC Marshall School of Business.
Email
Print
SPAM
LEAVE A COMMENT
